The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery - Trial NCT06334562
Access comprehensive clinical trial information for NCT06334562 through Pure Global AI's free database. This phase not specified trial is sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Timeline & Enrollment
N/A
May 01, 2024
Aug 31, 2025
Primary Outcome
Muscle relaxation recovery time
Summary
This study aims to compare the use of sugammadex (domestic) and neostigmine for antagonism
 after thoracic surgery, and observe the effect of sugammadex (domestic) on neuromuscular
 blockade antagonism after thoracic surgery, in order to provide a basis for optimizing the
 use of muscle relaxants and their antagonists during anesthesia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06334562
Non-Device Trial